Xingchun Zhou

843 total citations
22 papers, 649 citations indexed

About

Xingchun Zhou is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Xingchun Zhou has authored 22 papers receiving a total of 649 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Immunology and 5 papers in Cancer Research. Recurrent topics in Xingchun Zhou's work include Cancer, Hypoxia, and Metabolism (5 papers), Immunotherapy and Immune Responses (5 papers) and Immune Cell Function and Interaction (4 papers). Xingchun Zhou is often cited by papers focused on Cancer, Hypoxia, and Metabolism (5 papers), Immunotherapy and Immune Responses (5 papers) and Immune Cell Function and Interaction (4 papers). Xingchun Zhou collaborates with scholars based in China, United States and Slovenia. Xingchun Zhou's co-authors include Jinliang Xing, Yibing Chen, Peng Yuan, Shaogui Wan, Jianjun Zhu, Qi Yang, Jing Zhao, Tao Qin, Jin Yang and Dengke Bao and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Oncogene.

In The Last Decade

Xingchun Zhou

22 papers receiving 644 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Xingchun Zhou 323 246 123 113 73 22 649
Erin E. Childs 243 0.8× 246 1.0× 192 1.6× 108 1.0× 77 1.1× 12 648
Ann Lin 306 0.9× 212 0.9× 64 0.5× 90 0.8× 61 0.8× 15 662
Majid Zaki‐Dizaji 351 1.1× 454 1.8× 108 0.9× 153 1.4× 72 1.0× 55 982
Vassilios Atsaves 373 1.2× 130 0.5× 209 1.7× 116 1.0× 46 0.6× 19 619
Mark Tsang 351 1.1× 197 0.8× 124 1.0× 60 0.5× 53 0.7× 15 688
Lingxiao Xu 313 1.0× 283 1.2× 177 1.4× 82 0.7× 102 1.4× 49 843
Cristina Bértolo 229 0.7× 192 0.8× 162 1.3× 89 0.8× 59 0.8× 19 578
Torunn Bruland 238 0.7× 191 0.8× 124 1.0× 87 0.8× 77 1.1× 39 596
Léa Tourneur 472 1.5× 318 1.3× 225 1.8× 117 1.0× 59 0.8× 20 744
Haiting Mao 290 0.9× 368 1.5× 274 2.2× 162 1.4× 58 0.8× 37 827

Countries citing papers authored by Xingchun Zhou

Since Specialization
Citations

This map shows the geographic impact of Xingchun Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingchun Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingchun Zhou more than expected).

Fields of papers citing papers by Xingchun Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xingchun Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingchun Zhou. The network helps show where Xingchun Zhou may publish in the future.

Co-authorship network of co-authors of Xingchun Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Xingchun Zhou. A scholar is included among the top collaborators of Xingchun Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xingchun Zhou. Xingchun Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Bao, Dengke, Jing Zhao, Xingchun Zhou, et al.. (2019). Mitochondrial fission-induced mtDNA stress promotes tumor-associated macrophage infiltration and HCC progression. Oncogene. 38(25). 5007–5020. 171 indexed citations
3.
Yamashita, Takashi, Katja Lakota, Takashi Taniguchi, et al.. (2018). An orally-active adiponectin receptor agonist mitigates cutaneous fibrosis, inflammation and microvascular pathology in a murine model of systemic sclerosis. Scientific Reports. 8(1). 11843–11843. 40 indexed citations
4.
Zhang, Jing, Xingchun Zhou, Hulin Chang, et al.. (2016). Hsp60 exerts a tumor suppressor function by inducing cell differentiation and inhibiting invasion in hepatocellular carcinoma. Oncotarget. 7(42). 68976–68989. 32 indexed citations
5.
Wan, Shaogui, Yousheng Wu, Xingchun Zhou, et al.. (2015). Polymorphisms in Genes of Tricarboxylic Acid Cycle Key Enzymes Are Associated with Early Recurrence of Hepatocellular Carcinoma. PLoS ONE. 10(4). e0124471–e0124471. 4 indexed citations
6.
Guo, Xu, Cheng Chen, Boya Liu, et al.. (2015). Genetic variations in monocarboxylate transporter genes as predictors of clinical outcomes in non-small cell lung cancer. Tumor Biology. 36(5). 3931–3939. 12 indexed citations
7.
Guo, Xu, Deyang Li, Yousheng Wu, et al.. (2014). Genetic variants in genes of tricarboxylic acid cycle key enzymes are associated with prognosis of patients with non-small cell lung cancer. Lung Cancer. 87(2). 162–168. 14 indexed citations
8.
Yang, Fan, Xingchun Zhou, Xia Miao, et al.. (2014). MAGEC2, an epithelial-mesenchymal transition inducer, is associated with breast cancer metastasis. Breast Cancer Research and Treatment. 145(1). 23–32. 48 indexed citations
9.
Zhang, Yi, Peng Wang, Xingchun Zhou, et al.. (2014). Genetic Variations in the HIF1A Gene Modulate Response to Adjuvant Chemotherapy after Surgery in Patients with Colorectal Cancer. Asian Pacific Journal of Cancer Prevention. 15(11). 4637–4642. 7 indexed citations
10.
Yang, Fan, Xingchun Zhou, Yongjun Zhao, et al.. (2014). LIM and SH3 Domain Protein 1 (LASP-1) Overexpression Was Associated with Aggressive Phenotype and Poor Prognosis in Clear Cell Renal Cell Cancer. PLoS ONE. 9(6). e100557–e100557. 27 indexed citations
11.
Huang, Xiao‐Jun, Ping Qü, Yibing Chen, et al.. (2014). Low expression of CD112 is associated with poor overall survival in patients with hepatocellular carcinoma. Human Pathology. 45(9). 1944–1950. 11 indexed citations
12.
Qü, Ping, Xiao‐Jun Huang, Xingchun Zhou, et al.. (2014). Loss of CD155 expression predicts poor prognosis in hepatocellular carcinoma. Histopathology. 66(5). 706–714. 28 indexed citations
13.
Zhang, Tao, Jianhong Wang, Xingchun Zhou, et al.. (2014). Increased expression of TIGIT on CD4+T cells ameliorates immune-mediated bone marrow failure of aplastic anemia. Journal of Cellular Biochemistry. 115(11). n/a–n/a. 24 indexed citations
14.
Zhang, Jie, Xingchun Zhou, Haibin Zhang, et al.. (2014). Loss of expression of MHC class I-related chain A (MICA) is a frequent event and predicts poor survival in patients with hepatocellular carcinoma.. PubMed. 7(6). 3123–31. 40 indexed citations
15.
Zhou, Xingchun, et al.. (2013). The Ratio of Second to Fourth Digit Length (2D:4D) and Coronary Artery Disease in a Han Chinese Population. International Journal of Medical Sciences. 10(11). 1584–1588. 35 indexed citations
16.
Zhou, Xingchun, Fan Yang, Tao Zhang, et al.. (2013). Heterogeneous Expression of CT10, CT45 and GAGE7 Antigens and their Prognostic Significance in Human Breast Carcinoma. Japanese Journal of Clinical Oncology. 43(3). 243–250. 16 indexed citations
17.
Wang, Guodong, et al.. (2013). [Expressions of EZH2 and RUNX3 in renal cell carcinoma and their clinical significance].. PubMed. 29(1). 82–4, 88. 4 indexed citations
18.
Ma, Ying, Bei Liu, Bin Yuan, et al.. (2012). Sustained High Level of Serum VEGF at Convalescent Stage Contributes to the Renal Recovery after HTNV Infection in Patients with Hemorrhagic Fever with Renal Syndrome. SHILAP Revista de lepidopterología. 2012. 1–11. 30 indexed citations
19.
Liang, Xiangyan, Jian‐Kang Chen, Yufeng Zhao, et al.. (2011). Effect of Feining on bleomycin-induced pulmonary injuries in rats. Journal of Ethnopharmacology. 134(3). 971–976. 29 indexed citations
20.
Zhou, Xingchun, Chaojun Song, Xin Wang, Ying Tian, & Boquan Jin. (2007). [Preparation of the monoclonal antibodies against human BORIS and the expression pattern of BORIS in normal and diseased human mammary tissues].. PubMed. 23(4). 353–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026